Cited by 532Virus-based gene therapy researchT-cell and Retrovirus StudiesXenotransplantation and immune response

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer

Open access

Donahue, R E, Kessler, S W, Bodine, D, McDonagh, K, Dunbar, C, Goodman, S, Agricola, B, Byrne, E, Raffeld, M, Moen, R·1992·The Journal of Experimental Medicine

DOI 10.1084/jem.176.4.1125PMC PMC2119385

Open this paper in CoChat — free account Open PDF

Abstract

Moloney Murine Leukemia Virus (MoMuLV) causes T cell neoplasms in rodents but is not known to be a pathogen in primates. The core protein and enzyme genes of the MoMuLV genome together with an amphotropic envelope gene are utilized to engineer the cell lines that generate retroviral vectors for use in current human gene therapy applications. We developed a producer clone that generates a very high concentration of retroviral vector particles to optimize conditions for gene insertion into pluripotent hematopoietic stem cells. This producer cell line also generates a much lower concentration of replication-competent virus that arose through recombination. Stem cells from rhesus monkeys were purified by immunoselection with an anti-CD34 antibody, incubated in vitro for 80-86 h in the presence of retroviral vector particles with accompanying replication-competent virus and used to reconstitute recipients whose bone marrow had been ablated by total body irradiation. The retroviral vector genome was detected in circulating cells of five of eight transplant recipients of CD34+ cells and in the circulating cells of two recipients of infected, unfractionated bone marrow mononuclear cells. Three recipients of CD34+ cells had a productive infection with replication-competent virus. Six or seven mo after transplantation, each of these animals developed a rapidly progressive T cell neoplasm involving the thymus, lymph nodes, liver, spleen, and bone marrow. Lymphoma cells contained 10-50 copies of the replication-competent virus, but lacked the retroviral vector genome. We conclude that replication-competent viruses arising from producer cells making retroviral vectors can be pathogenic in primates, which underscores the importance of carefully screening retroviral producer clones used in human trials to exclude contamination with replication-competent virus.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1084/jem.176.4.1125

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
The biology of interleukin-6
Kishimoto, T. (1989) · Blood · doi:10.1182/blood.v74.1.1.bloodjournal7411 · Cited by 2,068
Improved retroviral vectors for gene transfer and expression.
Miller, A. D., & Rosman, G. J. (1989) · PubMed · Cited by 1,990
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus
Mann, R., Mulligan, R. C., & Baltimore, D. (1983) · Cell · doi:10.1016/0092-8674(83)90344-6 · Cited by 1,776
Redesign of Retrovirus Packaging Cell Lines To Avoid Recombination Leading to Helper Virus Production
Miller, A. D., & Buttimore, C. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.8.2895-2902.1986 · Cited by 1,371
Granulocyte colony-stimulating factor and its receptor
Demetri, G. D., & Griffin, J. D. (1991) · Blood · doi:10.1182/blood.v78.11.2791.2791 · Cited by 1,066
A safe packaging line for gene transfer: separating viral genes on two different plasmids
Markowitz, D., Goff, S. P., & Bank, A. (1988) · Journal of Virology · doi:10.1128/jvi.62.4.1120-1124.1988 · Cited by 1,062
Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges.
Danos, O., & Mulligan, R. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.17.6460 · Cited by 898
Human IL-3 (multi-CSF): Identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3
Yang, Y., Ciarletta, A. B., Temple, P. A., Chung, M. P., Kovacic, S., Witek-Giannotti, J. S., Leary, A. C., Kriz, R., Donahue, R. E., Wong, G. G., et al. (1986) · Cell · doi:10.1016/0092-8674(86)90360-0 · Cited by 766
Self-citation
Primary structure and functional expression of rat and human stem cell factor DNAs
Martin, F. H., Suggs, S. V., Langley, K. E., Lu, H. S., Ting, J., Okino, K. H., Morris, C. F., McNiece, I., Jacobsen, F. W., Mendlaz, E. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90301-t · Cited by 719

Show all 42 references

Sorted by citations

Items 301–400 of 525

An improved method for detection of replication-competent retrovirus in retrovirus vector products
Uchida, E., Sato, K., Iwata, A., Ishii‐Watabe, A., Mizuguchi, H., Hikata, M., Murata, M., Yamaguchi, T., & Hayakawa, T. (2004) · Biologicals · doi:10.1016/j.biologicals.2004.08.002 · Cited by 10
Site-specific gene modification by oligodeoxynucleotides in mouse bone marrow-derived mesenchymal stem cells
Flagler, K., Alexeev, V. Y., Pierce, E. A., & Igoucheva, O. (2008) · Gene Therapy · doi:10.1038/gt.2008.31 · Cited by 10
Comparative studies on cellular gene regulation by HIV-1 based vectors: implications for quality control of vector production
Zhao, Y., Azam, S. A., & Thorpe, R. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302414 · Cited by 10
Haematopoietic progenitor cells from the common marmoset as targets of gene transduction by retroviral and adenoviral vectors
Hibino, H., Tani, K., Sugiyama, H., Suzuki, S., Wu, M., Izawa, K., Hase, H., Nakazaki, Y., Tanabe, T., Ooi, J., et al. (2001) · European Journal Of Haematology · doi:10.1034/j.1600-0609.2001.066004272.x · Cited by 10
Gene-modified cells for the treatment of cancer
Whartenby, K. A., Abraham, G. N., Calabresi, P. A., Abboud, C. N., Calabresi, P., Marrogi, A. J., & Freeman, S. M. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)00081-d · Cited by 10
IMMUNOTHERAPY, INCLUDING GENE THERAPY, FOR METASTATIC MELANOMA
OʼRourke, M. G. E., Schmidt, C., O’Rourke, T., & Ellem, K. A. O. (1997) · Australian and New Zealand Journal of Surgery · doi:10.1111/j.1445-2197.1997.tb07607.x · Cited by 10
Transient In Vivo β-Globin Production After Lentiviral Gene Transfer to Hematopoietic Stem Cells in the Nonhuman Primate
Hayakawa, J., Ueda, T., Lisowski, L., Hsieh, M. M., Washington, K., Phang, O., Metzger, M., Krouse, A., Donahue, R. E., Sadelain, M., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2008.186 · Cited by 9
Self-citation
First-in-human autologous implantation of genetically modified adipocytes expressing LCAT for the treatment of familial LCAT deficiency
Aso, M., Yamamoto, T. T., Kuroda, M., Wada, J., Kubota, Y., Ishikawa, K., Maezawa, Y., Teramoto, N., Tawada, A., Asada, S., et al. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11271 · Cited by 9
Development of albumin microspheres containing Sp H1-DNA complexes: A novel gene delivery system
Okoroukwu, O. N., Green, G. R., & D’Souza, M. J. (2010) · Journal of Microencapsulation · doi:10.3109/02652040903052028 · Cited by 9
Chimeric T Cells for Adoptive Immunotherapy of Cancer: Using What Have We Learned to Plan for the Future
Peinert, S., Kershaw, M. H., & Prince, H. M. (2009) · Immunotherapy · doi:10.2217/imt.09.69 · Cited by 9
Synthesis and Characterization of Vitamin D 3 -Functionalized Carbon Dots for Crispr/Cas9 Delivery
Hasanzadeh, A., Radmanesh, F., Hosseini, E. S., Hashemzadeh, I., Kiani, J., Naseri, M., Nourizadeh, H., Fatahi, Y., Azar, B. K. Y., Marani, B. G., et al. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0038 · Cited by 9
Anti-tumor effects and tumor immunogenicity following IL2 or IL4 cytokine gene transfection of three mouse mammary tumors
Matory, Y. L., Chen, M., Goedegebuure, P. S., & Eberlein, T. J. (1995) · Annals of Surgical Oncology · doi:10.1007/bf02307083 · Cited by 9
Understanding Xenotransplantation Risks from Nonhuman Primate Retroviruses
Allan, J. (2003) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-55541-1_5 · Cited by 9
Mitigating Cross-Species Viral Infections in Xenotransplantation: Progress, Strategies, and Clinical Outlook
Zhou, Y., Zhou, S., Wang, Q., & Zhang, B. (2024) · Cell Transplantation · doi:10.1177/09636897241226849 · Cited by 8
Design of pH‐sensitive peptides from natural antimicrobial peptides for enhancing polyethylenimine‐mediated gene transfection
Zhang, S., Song, J., Li, S.-B., Gao, H., Chang, H., Jia, L., Gong, F., Tan, Y., & Ji, S. (2017) · The Journal of Gene Medicine · doi:10.1002/jgm.2955 · Cited by 8
Comparison of toxicogenomic profiles of two murine strains treated with HIV-1-based vectors for gene therapy
Zhao, Y., Keating, K., & Thorpe, R. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.08.008 · Cited by 8
A reporter system for replication-competent gammaretroviruses: the inGluc-MLV-DERSE assay
Aloia, A. L., Duffy, L., Pak, V., Lee, K. E., Sánchez-Martínez, S., Derse, D., Heidecker, G., Cornetta, K. G., & Rein, A. (2012) · Gene Therapy · doi:10.1038/gt.2012.18 · Cited by 8
The evolution of gene therapy in X-linked severe combined immunodeficiency
Rans, T. S., & England, R. W. (2009) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60504-2 · Cited by 8
Ethanol treatment a Non-extrusion method for asymmetric liposome size optimization
Mokhtarieh, A. A., Davarpanah, S. J., & Lee, M. K. (2013) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-21-32 · Cited by 8
Regulated Expression of Artificial Chimeric Genes Contained in Retroviral Vectors: Implications for Virus-Directed Enzyme Prodrug Therapy (VDEPT) and other Gene Therapy Applications
Huber, B. E., & Richards, C. A. (1996) · Journal of drug targeting · doi:10.3109/10611869608996826 · Cited by 8
The Effect of Selection for High-Level Vector Expression on the Genetic and Functional Stability of a Single Transcript Vector Derived from a Low-Leukemogenic Murine Retrovirus
Duch, M., Paludan, K., Lovmand, J., Sørensen, M. S., Jørgensen, P., & Pedersen, F. S. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.3-289 · Cited by 8
Gene therapy for paediatric leukaemia
Heslop, H. E., Rousseau, R. F., & Bollard, C. M. (2001) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.1.4.663 · Cited by 8
Basic principles associated with gene therapy of cancer
Geraghty, P. J., & Chang, A. E. (1995) · Surgical Oncology · doi:10.1016/s0960-7404(10)80017-9 · Cited by 8
Replication of enhancer-deficient amphotropic murine leukemia virus in human cells
Reuss, F. U., Berdel, B., Ploß, M., & Heber, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191182098 · Cited by 8
Physical method for gene transfer: an alternative to viruses
Fouillard, L. (1996) · Hematology and Cell Therapy · doi:10.1007/s00282-996-0214-6 · Cited by 8
Retroviruses and cancer
Weiss, R. A. (2000) · UCL Discovery (University College London) · doi:10.1007/978-1-59259-024-7_11 · Cited by 8
Chapter 8-Clinical Issues in the Development of Cellular Systems for Use as Bone Graft Substitutes
Attawia, M., Rosier, R. N., Whang, P., & Lieberman, J. R. (2003) · doi:10.1520/mono10065m · Cited by 8
Analysis of two monoclonal antibodies reactive with envelope proteins of murine retroviruses: One pan specific antibody and one specific for Moloney leukemia virus
Evans, L. H., Boi, S., Malik, F., Wehrly, K., Peterson, K. E., & Chesebro, B. W. (2014) · Journal of Virological Methods · doi:10.1016/j.jviromet.2014.02.006 · Cited by 8
Amphotropic Murine Leukemia Virus Replication in Human Mammary Epithelial Cells and the Formation of Cytomegalovirus–Promoter Recombinants
Reuss, F. U., Heber, R., Ploß, A., & Berdel, B. (2001) · Virology · doi:10.1006/viro.2001.1199 · Cited by 7
Genetic engineering of onco/lentivirus hybrids results in formation of infectious but not of replication-competent viruses
Steidl, S., Schüle, S., Mühlebach, M. D., Stitz, J., Böller, K., Cichutek, K., & Schweizer, M. (2004) · Journal of General Virology · doi:10.1099/vir.0.19479-0 · Cited by 7
Inhibition of Human Immunodeficiency Virus Type 1 by Packageable, Multigenic Antisense RNA
Shahabuddin, M., & Khan, A. S. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.2000.10.141 · Cited by 7
Human genetic therapy
Harris, J. M., & Sikora, K. (1993) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(93)90021-5 · Cited by 7
Retroviral transfer of themultidrug resistance‐1 gene into lineage‐committed and primitive hemopoietic cells
Früehauf, S., Boesen, J. J. B., Breems, D. A., wenberg, B. L., Ploemacher, R., Höft, R., rfer, P. H. O., Zeller, W. J., Haas, R. R., & Valerio, D. (1995) · Stem Cells · doi:10.1002/stem.5530130715 · Cited by 7
Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells
Finger, C., Sun, Y., Sanz, L., Álvarez‐Vallina, L., Buchholz, C. J., & Cichutek, K. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700805 · Cited by 7
Genetic immunotherapy for cancer
Elmslie, R. E., & DOW, S. W. (1997) · Topics in companion animal medicine · doi:10.1016/s1096-2867(97)80033-3 · Cited by 7
Use of a Nonviral Vector to Express a Chimeric tRNA-Ribozyme Against Lymphocytic Choriomeningitis Virus: Cytoplasmic Accumulation of a Catalytically Competent Transcript but Minimal Antiviral Effect
Gebhard, J. R., PERRY, C. M., MAHADEVIAH, S., & Whitton, J. L. (1997) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1997.7.3 · Cited by 7
Cytokine Gene Therapy for Human Tumors
Angelica, M. D., & Fong, Y. (1998) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30259-x · Cited by 7
Recent Advances in Canine Medicine
Fonseca‐Alves, C. E. (2022) · Veterinary medicine and science · doi:10.5772/intechopen.100825 · Cited by 6
T Cells Mediate Treatment of Six-Day-Old Cytokine-Gene-Transfected Mouse Mammary Tumor
Matory, Y. L., Dorfman, D. M., Chen, M., Wu, L., Spanjaard, R. A., Goedegebuure, P. S., & Eberlein, T. J. (1999) · Pathobiology · doi:10.1159/000028044 · Cited by 6
Potential of gene therapy for myocardial ischemia
Hermonat, P. L., & Mehta, J. L. (2004) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000136452.01448.5b · Cited by 6
Gene Therapy as a Therapeutic Intervention for Vascular Disease
Meyerson, S. L., & Schwartz, L. B. (1999) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-199907000-00009 · Cited by 6
The Use of Suicide Gene Therapy for the Treatment of Malignancies of the Brain
Judy, K. D., & Eck, S. L. (2002) · Elsevier eBooks · doi:10.1016/b978-012437551-2/50034-3 · Cited by 6
Lentiviral and Retroviral Vector Systems
Stripecke, R., & Kasahara, N. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-222-9_3 · Cited by 6
pa317 Retrovirus Packaging Cells
Miller, A. D. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0728 · Cited by 6
Preclinical Safety Evaluation of Biopharmaceuticals
Serabian, M. A., & Huang, Y. (2010) · Pharmaceutical Sciences Encyclopedia · doi:10.1002/9780470571224.pse191 · Cited by 6
The Role of Herpes Simplex Thymidine Kinase Gene Transfer in the Drug Treatment of Brain Tumours
Culver, K. W. (1996) · CNS Drugs · doi:10.2165/00023210-199606010-00001 · Cited by 6
Retroviral Vectors in Human Gene Therapy
Morgan, R. A. (1995) · Springer eBooks · doi:10.1007/978-94-011-0555-2_4 · Cited by 6
No Evidence of Xenotropic Murine Leukemia Virus-Related Virus Transmission by Blood Transfusion from Infected Rhesus Macaques
Williams, D. K., Galvin, T. A., Gao, Y. S., O'Neill, C., Glasner, D. R., & Khan, A. S. (2012) · Journal of Virology · doi:10.1128/jvi.02326-12 · Cited by 5
Human primary T lymphocytes have a low capacity to amplify MLV-based amphotropic RCR and the virions produced are largely noninfectious
Ebeling, S. B., Simonetti, E. R., Borst, H. P. E., Blok, A., Schelen, A. M., Braakman, E., Ederveen, J., & Hagenbeek, A. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302080 · Cited by 5
Recombinant DNA Technology: A 20-Year Occupational Health Retrospective
Cohen, R., & HOERNER, C. L. (1996) · Reviews on Environmental Health · doi:10.1515/reveh.1996.11.3.149 · Cited by 5
α-Gal Epitopes on Viral Glycoproteins
Rother, R. P., & Galili, U. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4771-6_7 · Cited by 5
Regulation of gene therapy in Europe: a current statement including reference to US regulation
Cohen‐Haguenauer, O. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90483-9 · Cited by 5
Retrovirus molecular conjugates: a versatile and efficient gene transfer vector system for primitive human hematopoietic progenitor cells
Yang, G., Zhong, Q., Huang, W., Reiser, J., & Schwarzenberger, P. O. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700911 · Cited by 5
Retroviral vectors and gene therapy: An update
Maurya, S. K., Srivastava, S., & Joshi, R. (2009) · Cited by 5
GENE-BASED THERAPEUTICS
Fradkin, L. G., Ropp, J. D., & Warner, J. F. (2000) · Elsevier eBooks · doi:10.1016/b978-012436630-5/50034-9 · Cited by 5
Retroviral Vectors for Gene Therapy
Kim, S., & Robbins, P. D. (2007) · Springer eBooks · doi:10.1007/978-0-387-70909-3_5 · Cited by 5
Adeno-associated Virus Based Vectors As Antivirals
Wong, K. K., & Chatterjee, S. S. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-80207-2_9 · Cited by 5
Stable transfection of rat preproinsulin II gene into rat hematopoietic stem cells via recombinant adeno-associated virus
Shah, R., & Jindal, R. M. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00471-3 · Cited by 5
AIDS and HIV infection
Smith, C. A., & Sullenger, B. A. (1995) · Springer eBooks · doi:10.1007/978-94-011-0547-7_11 · Cited by 5
New vectors for gene therapy
Grez, M., & von Melchner, H. (2009) · Stem Cells · doi:10.1002/stem.5530160828 · Cited by 5
Autologous Bone Marrow Transplantation
McCarthy, L. J., Danielson, C., Cornetta, K. G., Srour, E. F., Broun, E. R., & Armitage, J. O. (1995) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369509084682 · Cited by 5
Treatment of Established Tumor Is Associated with ICAM-1 Upregulation and Reversed by CD8 Depletion in a Tumor Necrosis Factor-Alpha Gene Transfected Mouse Mammary Tumor
Matory, Y. L., Dorfman, D. M., Wu, L., Chen, M., Goedegebuure, P. S., & Eberlein, T. J. (1999) · Pathobiology · doi:10.1159/000028071 · Cited by 5
Gene therapy and gastrointestinal cancer: concepts and clinical facts
Hauses, M., & Schackert, H. K. (1999) · Langenbeck s Archives of Surgery · doi:10.1007/s004230050234 · Cited by 5
Somatic gene therapy and its implications in melanoma treatment
Möller, P., & Schadendorf, D. (1997) · Archives of Dermatological Research · doi:10.1007/s004030050157 · Cited by 5
Overview: Retroviral Vectors for Gene Therapy and Transgenics
Hodgson, C. P., Chakraborty, A. K., & Boman, B. M. (1993) · Current Opinion on Therapeutic Patents · doi:10.1517/13543776.3.2.223 · Cited by 5
Retroviral Vector Design for Cancer Gene Therapy
Baum, C., Ostertag, W., von Laer, D., & Stocking, C. (2002) · Elsevier eBooks · doi:10.1016/b978-012437551-2/50002-1 · Cited by 5
Gibbon Ape Leukemia Virus Poorly Replicates in Primary Human T Lymphocytes
Lamers, C. H. J., Willemsen, R. A., van Elzakker, P., Gratama, J. W., & Debets, R. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318199840a · Cited by 4
Current status and future prospects of human gene therapy
Shimada, T. (1996) · Pediatrics International · doi:10.1111/j.1442-200x.1996.tb03465.x · Cited by 4
Regulation of gene therapy: The Canadian approach
Ridgway, A. A. G. (1995) · Biologicals · doi:10.1016/1045-1056(95)90008-x · Cited by 4
Myeloablative irradiation in non‐human primates
Watts, K. L., Beard, B., Wood, B. L., & Kiem, H. (2009) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.2009.00368.x · Cited by 4
Generation of Retroviral Packaging and Producer Cell Lines for Large-Scale Vector Production with Improved Safety and Titer
Dubensky, T. W., & Sauter, S. L. (2003) · Humana Press eBooks · doi:10.1385/1-59259-304-6:309 · Cited by 4
Gene Therapy in Human Cancer: Report of Human Clinical Trials
Wasil, T., & Buchbinder, A. (2000) · Cancer Investigation · doi:10.3109/07357900009012206 · Cited by 4
Gene Therapy for Severe Combined Immunodeficiency Disease
Handgretinger, R., Kościelniak, E., & NIETHAMMER, D. (2002) · New England Journal of Medicine · doi:10.1056/nejm200208223470814 · Cited by 4
Retroviruses in Human Gene Therapy
Pedersen, F. S., & Mikkelsen, J. G. (2018) · Wiley eBooks · doi:10.1002/9780470015902.a0001002.pub4 · Cited by 4
Getting human gene therapy to work
Stewart, F. M. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240580404 · Cited by 4
Gene transfer into human haematopoietic stem cells
Péault, B., & Charbord, P. (1997) · Transfusion Science · doi:10.1016/s0955-3886(97)00021-0 · Cited by 4
Retrovirus molecular conjugates
Zhong, Q., Kolls, J. K., & Schwarzenberger, P. O. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s000180200008 · Cited by 4
Applications of gene transfer to cellular immunotherapy
Terando, A. M., & Chang, A. E. (2002) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(02)00024-8 · Cited by 4
Transduction of Feline Hematopoietic Cells by Oncoretroviral Vectors Pseudotyped with the Subgroup A Feline Leukemia Virus (FeLV-A)
Josephson, N. C., Sabo, K. M., & Abkowitz, J. L. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0090 · Cited by 4
Regulatory Issues in Gene-Modified Immune Effector Cell Therapy
Cornetta, K. G., & Komanduri, K. V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-66181-2.00014-7 · Cited by 3
Quality Control Testing of Biologics
RSHEK, W. (2007) · Elsevier eBooks · doi:10.1016/b978-012369454-6/50077-7 · Cited by 3
RNA Interference-Based Therapeutics: Harnessing the Powers of Nature
Martı́nez, T., Wright, N., Pañeda, C., Ana, I., & Lopez-Frag, M. (2011) · InTech eBooks · doi:10.5772/29576 · Cited by 3
Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiency
Montiel-Equihua, C., Thrasher, A. J., & Gaspar, H. B. (2009) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s5570 · Cited by 3
Recombinant human parvovirus B19 vectors
Weigel-Kelley, K. A., & Srivastava, A. (2002) · Pathologie Biologie · doi:10.1016/s0369-8114(02)00310-3 · Cited by 3
DNA Methylation of Helper Virus Increases Genetic Instability of Retroviral Vector Producer Cells
Young, W., Lindberg, G. L., & Link, C. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3177-3187.2000 · Cited by 3
Gene Therapy for Cardiovascular Disease
Meyerson, S. L., Skelly, C. L., Curi, M. A., & Schwartz, L. B. (2000) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/108925320000400410 · Cited by 3
Vectors and target cells for gene therapy of blood diseases
Qazilbash, M. H., Young, N. S., & Liu, J. (1996) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(95)00127-1 · Cited by 3
Clinical Approaches to Cancer Gene Therapy
Whartenby, K. A., Marrogi, A. J., & Freeman, S. M. (1998) · Springer eBooks · doi:10.1007/978-94-009-0029-5_21 · Cited by 3
Methoden der Genübertragung
Rüger, R. (1997) · Springer eBooks · doi:10.1007/978-3-662-08822-7_6 · Cited by 3
Retroviral gene therapy in hematopoietic diseases
Cornetta, K. G., & Fan, Y. (1997) · Journal of Clinical Apheresis · doi:10.1002/(sici)1098-1101(1997)12:4 · Cited by 3
Success for gene therapy: render unto Caesar that which is Caesar's.
Qiao, J., Díaz, R. M., & Vile, R. G. (2004) · Genome biology · doi:10.1186/gb-2004-5-8-237 · Cited by 3
Current Status of Retroviral Vector Mediated Gene Transfer into Human Hematopoietic Stem Cells
Elwood, N. J., & Smith, C. A. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109060338 · Cited by 3
Gene Transfer and Therapeutic Drug Monitoring
Brenner, M. K. (1996) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199608000-00002 · Cited by 3
Gene Therapy for HIV Infection
Poznansky, M. C., McClure, M. O., & Adams, G. B. (1998) · Biotechnology · doi:10.1002/9783527620869.ch21 · Cited by 3
Retroviral Vectors for Human Gene Therapy
Ferrari, G., & Mavilio, F. (1998) · Springer eBooks · doi:10.1007/978-3-642-72160-1_13 · Cited by 3
[Virus detection by electron microscopy: past, present and future].
Roingeard, P. (2009) · PubMed · doi:10.1684/13-5.2011.249-258-article-1 · Cited by 2
Viral vectors for gene therapy
Tsai, A., Suzuki‐Hatano, S., & Pacak, C. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00019-8 · Cited by 2
Clinical Grade Lentiviral Vectors
Kochan, G. T., Escors, D., Stephenson, H. N., & Breckpot, K. (2012) · SpringerBriefs in biochemistry and molecular biology · doi:10.1007/978-3-0348-0402-8_5 · Cited by 2
Insertional mutagenesis and gene therapy
Cavazzana, M., & Gisselbrecht, S. (2005) · Hématologie · Cited by 2
A gene delivery system based on the N-terminal domain of human topoisomerase I
Chen, Y., Kuo, H.-C., Chen, Y.-M., Huang, S.-Y., Liu, Y.-R., Lin, S.-C., Yang, H., & Chen, T.-Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.041 · Cited by 2

Authors: Donahue, R. E., Kessler, S. W., Bodine, D., McDonagh, K., Dunbar, C., Goodman, S., Agricola, B., Byrne, E., Raffeld, M., & Moen, R.
Affiliations: National Institutes of Health (US)
ORCID: Donahue, R E
Kessler, S W
Bodine, D
Dunbar, C
Raffeld, M
Moen, R
Venue: The Journal of Experimental Medicine
Publisher: Rockefeller University Press
Published: 1992-10-01
Volume: 176
Issue: 4
Pages: 1125-1135
ISSN: 0022-1007 (ISSN-L)
1540-9538
DOI: 10.1084/jem.176.4.1125
PMC: PMC2119385
OpenAlex: W2132859839
Cited by: 532
References: 42
Citations by year: 2026: 3 · 2025: 2 · 2024: 3 · 2022: 8 · 2021: 4 · 2020: 3 · 2019: 5 · 2018: 10 · 2017: 7 · 2015: 8 · 2014: 11 · 2013: 5 · 2012: 9
FWCI: 17.91
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: The Journal of Experimental Medicine (publishedVersion)
PubMed Central (publishedVersion, cc-by-nc-sa)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
Health Sciences › Medicine › Surgery › Xenotransplantation and immune response
Keywords: Moloney murine leukemia virus, retroviral vectors, replication-competent virus, T-cell lymphoma, helper virus, retroviral gene transfer, CD34+ hematopoietic stem cells, bone marrow transplantation, rhesus monkeys, non-human primates, gene therapy safety, thymic lymphoma
MeSH terms: Animals, Antibodies, Monoclonal, Antigens, Differentiation, Base Sequence, Cells, Cultured, DNA, Neoplasm, DNA, Viral, Globins, Helper Viruses, Macaca mulatta, Molecular Sequence Data, Moloney murine leukemia virus, Oligodeoxyribonucleotides, Time Factors, Transfection, Virus Replication, Antigens, CD, Bone Marrow Transplantation, Lymphoma, T-Cell, Genome, Viral, Antigens, CD34

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks